Ting Bao

Dr. Ting Bao

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2022 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
JFJiajia Fu
Jiajia Fu
YHYan Huang
Yan Huang
TBTing Bao
Ting Bao
CLChengcheng Liu
Chengcheng Liu
XLXi Liu
Xi Liu
Xueping ChenXueping Chen
Xueping Chen
Neurodegenerative diseases are a group of disorders characterized by progressive loss of certain populations of neurons, which eventually lead to dysfunction. These diseases include Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Immune pathway dysregulation is one of the common features of neurodegeneration. Recently, there is growing interest in the specific role of T helper Th 17 cells and Interleukin-17A (IL-17A), the most important cytokine of Th 17 cells, in the pathogenesis of the central nervous system (CNS) of neurodegenerative diseases. In the present study, we summarized current knowledge about the function of Th17/IL-17A, the physiology of Th17/IL-17A in diseases, and the contribution of Th17/IL-17A in AD, PD, and ALS. We also update the findings on IL-17A-targeting drugs as potentially immunomodulatory therapeutic agents for neurodegenerative diseases. Although the specific mechanism of Th17/IL-17A in this group of diseases is still controversial, uncovering the molecular pathways of Th17/IL-17A in neurodegeneration allows the identification of suitable targets to modulate these cellular processes. Therapeutics targeting IL-17A might represent potentially novel anti-neurodegeneration drugs.

6 November 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
X徐Xu 徐华雪 徐
Xu 徐华雪 徐
JFJiajia Fu
Jiajia Fu
Risna Begam Mohammed NazarRisna Begam Mohammed Nazar
Risna Begam Mohammed Nazar
JYJing Yang
Jing Yang
SCSihui Chen
Sihui Chen
Xueping ChenXueping Chen
Xueping Chen
Prior studies have yielded mixed findings concerning the association between apolipoprotein E(APOE)-ε4 and serum lipids in patients with Alzheimer’s disease (AD) and healthy individuals. Some studies suggested a relationship between APOEε4 and serum lipids in patients with AD and healthy individuals, whereas others proposed that the APOEε4 allele affects lipids only in patients with AD. Our study aimed to investigate whether APOE alleles have a distinct impact on lipids in AD. We conducted a comprehensive search of the PubMed and Embase databases for all related studies that investigate APOE and serum lipids of AD from the inception to 30 May 2022. Elevated total cholesterol (TC) and low-density lipoprotein (LDL) levels were found in APOEε4 allele carriers compared with non-carriers. No significant differences were found for high-density lipoprotein (HDL) and triglyceride (TG) levels in APOEε4 allele carriers compared to non-carriers. Notably, elevated TC and LDL levels showed considerable heterogeneity between patients with AD and healthy controls. A network meta-analysis did not find a distinct effect of carrying one or two APOEε4 alleles on lipid profiles. Higher TC and LDL levels were found in APOEε4 allele carriers compared with non-carriers, and the difference was more significant in patients with AD than in healthy controls.

10 June 2024 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
PDF file
WTWenjuan Tao
Wenjuan Tao
TBTing Bao
Ting Bao
TGTao Gu
Tao Gu
JPJay Pan
Jay Pan
WLWeimin Li
Weimin Li
RLRuicen Li
Ruicen Li
Background: Lung cancer screening (LCS) with low-dose computed tomography (LDCT) is an efficient method that can reduce lung cancer mortality in high-risk individuals. However, few studies have attempted to measure the preferences for LDCT LCS service delivery. This study aimed to generate quantitative information on the Chinese population’s preferences for LDCT LCS service delivery. Methods: The general population aged 40 to 74 in the Sichuan province of China was invited to complete an online discrete choice experiment (DCE). The DCE required participants to answer 14 discrete choice questions comprising five attributes: facility levels, facility ownership, travel mode, travel time, and out-of-pocket cost. Choice data were analyzed using mixed logit and latent class logit models. Results: The study included 2,529 respondents, with 746 (29.5%) identified as being at risk for lung cancer. Mixed logit model analysis revealed that all five attributes significantly influenced respondents’ choices. Facility levels had the highest relative importance (44.4%), followed by facility ownership (28.1%), while out-of-pocket cost had the lowest importance (6.4%). The atrisk group placed relatively more importance on price and facility ownership compared to the nonrisk group. Latent class logit model identified five distinct classes with varying preferences. Conclusion: This study revealed significant heterogeneity in preferences for lung cancer screening service attributes among the Chinese population, with facility level and facility ownership being the most important factors. The findings underscore the need for tailored strategies targeting different subgroup preferences to increase screening participation rates and improve early detection outcomes.

10 November 2023
Verified
Report
Closed access
TBTing Bao
Ting Bao
BLBingqing Liu
Bingqing Liu
DLDanting Li
Danting Li
JDJiale Du
Jiale Du
JFJinhua Feng
Jinhua Feng
BSBairong Shen
Bairong Shen
INPLASY2023110047 Prevention of exercise-related injuries and adverse events in patients with diabetes:a scoping review Keywords: Diabetes; scoping review; exercise; physical activity; adverse even…

5 September 2026
Verified
Conference Paper
Closed access
TBTing Bao
Ting Bao
YZYuan Zhu
Yuan Zhu
WLWenyu Li
Wenyu Li
RLRuicen Li
Ruicen Li
YLYidan Lin
Yidan Lin
Objectives: This prospective cohort study tracks anxiety and depression trajectories from preoperative to 6 months post‑lung nodule resection. The psychological impact is a key concern, as early lung cancer often lacks physical symptoms. Methods: We enrolled 608 consecutive patients undergoing pulmonary resection for clinically highly suspected lung cancer. Postoperative pathology identified 34 benign and 574 malignant nodules. Pain, anxiety, and depression were assessed preoperatively (day 1) and postoperatively (days 1, 3, 7; months 3, 6) using the Amsterdam Preoperative Anxiety and Information Scale (APAIS), Faces Pain Scale–Revised (FPS‑R), Visual Analog Scale for Anxiety (VAS‑A), Patient Health Questionnaire‑9 (PHQ‑9), and Generalized Anxiety Disorder‑7 (GAD‑7). Group-based longitudinal trajectories were analyzed via linear mixed-effects models. Results: Our team's diagnostic accuracy for lung cancer via Low-Dose Computed Tomography (LDCT) was 94.4%. Nodule size did not differ between benign (0.97±0.49 cm) and malignant groups (1.05±0.52 cm, P>0.05). Pain, anxiety, and depression improved significantly over time in both groups (time effect: P<0.05). Preoperative anxiety and depression prevalence were similar (~12% each). Postoperatively, depression (4.53%, 1.22%) and anxiety (3.31%, 1.05%) persisted in the malignant group at 3 and 6 months, with no new cases in the benign group. Conclusions: Pain, anxiety, and depression improved similarly after surgery in all patients, indicating that the surgical procedure, more than the benign or malignant diagnosis, was the key factor in short-term psychological adaptation.

10 December 2024 in JMIR Preprints
Verified
Preprint
Open access
TBTing Bao
Ting Bao
XLXingyun Liu
Xingyun Liu
SRShumin Ren
Shumin Ren
KZKe Zhang
Ke Zhang
JDJiale Du
Jiale Du
BSBairong Shen
Bairong Shen
BACKGROUND Exercise plays a critical role in managing diabetes, improving glycemic control, and reducing the risk of cardiovascular complications. However, personalizing exercise prescriptions (PEPs) to address individual characteristics and preferences is challenging, particularly in an environment with a global shortage of exercise professionals. While digital tools hold promise for improving personalized care, many existing systems rely on generalized guidelines or expert consensus, lacking the ability to provide highly individualized and evidence-based recommendations. To address this gap, we developed PEP-DSS-DBC1.0, a knowledge-based digital decision support system for generating tailored PEPs in diabetes care. OBJECTIVE The aim of this study was to create a digital, knowledge-based decision support tool for personalized exercise prescriptions that incorporates individual characteristics and preferences. PEP-DSS-DBC1.0 was designed to enhance the precision and usability of PEPs for people with diabetes while ensuring alignment with evidence-based principles. METHODS The development of PEP-DSS-DBC1.0 was informed by an extensive review of the literature. A working group, including experts in exercise medicine, diabetes care, and informatics, was formed to establish a decision support framework. The PubMed database served as the primary resource for knowledge extraction, covering studies published between January 1975 and May 2023. Data from 938 studies were annotated, resulting in 1,171 exercise protocols, 10,316,497 patient records, and 2,904 additional entries, totaling 13,263 data points. The web-based tool was built using a browser/server architecture and the WIMA (Windows, IIS, MySQL, ASP.NET) web stack. Validation and comparative analysis of the tool were performed against ChatGPT4o and sports physicians, using multiple metrics and two rating scales: the System Usability Scale (SUS) and the Net Promoter Score (NPS). RESULTS PEP-DSS-DBC1.0 provides personalized exercise prescriptions based on the newly developed “FITT-VP-WC” principles, which include frequency, intensity, time, type, volume, progression, warning, and contraindication. The tool demonstrated superior performance compared to ChatGPT4o and sports physicians, achieving a total performance score of 100% compared to 48% for ChatGPT4o and 12% for sports physicians (χ2=853.3, P<.001). Usability assessments showed that the average SUS score was 77.25 ± 6.06, indicating above-average usability, while the NPS score was 68.75%, reflecting high user loyalty and satisfaction. The tool is freely accessible at http://PEP-DSS-DBC.sysbio.org.cn/. CONCLUSIONS PEP-DSS-DBC1.0 represents a significant advancement in diabetes care, providing a knowledge-based system for generating highly individualized exercise prescriptions. While the tool has demonstrated superior performance and usability, future randomized controlled trials are essential to further validate its clinical utility and broader application in diabetes management.